FLT1 and cancer: Sunitinib is a multi-kinase inhibitor, targeting VEGFR1,2,3 and PDGFRα,β, which reduces angiogenesis, resulting in diminished oxygen supply to cancer cells, thereby inhibiting cancer cell growth (40).